Drug Trial Radar · NCT07700238
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Newly Diagnosed Previously Untreated Primary Immune Thrombocytopenia (ITP)
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
126
Planned (sponsor's estimate)
Start
Oct 15, 2026
Primary completion
Sep 14, 2029
Study completion Oct 14, 2029
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jul 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 study is designed to evaluate the efficacy and safety of romiplostim in combination with predniso(lo)ne compared with predniso(lo)ne alone in adults with previously newly diagnosed untreated Primary Immune Thrombocytopenia (ITP).
Conditions
- Primary Immune Thrombocytopenia
Interventions
RomiplostimDrug
Administered subcutaneously.
Predniso(lo)neDrug
Administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With a Durable Platelet Response (DPR)Time frame: 8 weeks
Locations
21 sites in 5 countries. Site status is shown where the registry gives one.
MemorialCare Long Beach Medical Center
Long Beach, California · Recruiting
The Bleeding and Clotting Disorders Institute
Peoria, Illinois · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Hematology Oncology Associates of Fredericksburg
Fredericksburg, Virginia · Recruiting
Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin
Berlin, Germany · Recruiting
Universitaetsklinikum Dresden
Dresden, Germany · Recruiting
Klinikum der Justus-Liebig-Universitaet
Giessen, Germany · Recruiting
Universitaetsklinikum Jena
Jena, Germany · Recruiting
Semmelweis Egyetem
Budapest, Hungary · Recruiting
Debreceni Egyetem Klinikai Kozpont
Debrecen, Hungary · Recruiting
Heves Varmegyei Markhot Ferenc Oktatokorhaz es Rendelointezet
Eger, Hungary · Recruiting
Pecsi Tudomanyegyetem Klinikai Kozpont
Kaposvár, Hungary · Recruiting
Hospital General Universitario Gregorio Maranon
Madrid, Spain · Recruiting
Hospital General Universitario Morales Meseguer
Murcia, Spain · Recruiting
Hospital Universitario Virgen del Rocio
Seville, Andalusia, Spain · Recruiting
Hospital Universitari Vall d Hebron
Barcelona, Catalonia, Spain · Recruiting
Adnan Menderes Universitesi Tip Fakultesi
Aydin, Turkey (Türkiye) · Recruiting
Trakya Universitesi Tip Fakultesi
Edirne, Turkey (Türkiye) · Recruiting
Istanbul Universitesi Cerrahpasa Tip Fakultesi
Istanbul, Turkey (Türkiye) · Recruiting
Bagcilar Medipol Mega Universite Hastanesi
Istanbul, Turkey (Türkiye) · Recruiting
Kocaeli Universitesi Tip Fakultesi Hastanesi
Kocaeli, Turkey (Türkiye) · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.